Cite
HARVARD Citation
Meleshko, A. et al. (2017). Phase I clinical trial of idiotypic DNA vaccine administered as a complex with polyethylenimine to patients with B-cell lymphoma. Human vaccines & immunotherapeutics. 13 (6), pp. 1398-1403. [Online].